Treatment Can Work. SELECT A TOPIC...

Size: px
Start display at page:

Download "Treatment Can Work. SELECT A TOPIC..."

Transcription

1 Page 1 of 8 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Treatment Can Work Drug Treatment Works Research has revealed a number of basic principles that underlie effective drug addiction treatment, as highlighted in NIDA s Principles of Drug Addiction Treatment: A Research-Based Guide. NIDA's Principles of Treatment No single treatment is appropriate for all individuals. Treatment needs to be readily available. Treatment must attend to multiple needs of the individual, not just drug use. Multiple courses of treatment may be required for success. Remaining in treatment for an adequate period of time is critical for treatment effectiveness. Magnitude Faces of Addiction Trends in Drug Abuse Addiction is a Chronic Disease Treatment Can Work Prevention Can Work Stigma of Drug Abuse References Drug addiction can be effectively treated with behaviorbased therapies and, for some drugs, such as heroin or nicotine, with medications. Additionally, treatment reduces the risk of HIV

2 Page 2 of 8 infection and can improve the prospects for employment. Treatment for Drug Abuse and Addiction is Delivered in Many Different Settings Treatment Works Pre- and post-treatment self-reported changes among those in long-term residential TCs Source: Hubbard et al., Therapeutic communities (TCs) focus on the community as the therapeutic ingredient for facilitating change. The treatment usually consists of full-time engagement with a community of peers and staff members, in a residential setting. Most therapeutic communities consider 6 to 12 months to be the recommended duration of treatment. 2 Behaviors of Adolescents Before and One Year After Treatment

3 Page 3 of 8 Source: Hser et al., Programs tailored to treating adolescents can reduce drug use and criminal activity and improve school performance. Medications Can Be Useful Buprenorphine Works! Source: Ling et al., An increase in the percentage of opiate-free urine specimens is associated with

4 Page 4 of 8 higher doses of buprenorphine. Such pharmacotherapy for the treatment of addiction is now available in medical office settings. Studies have shown long-lasting effects with continued treatment. In one study, those that stayed in treatment had urine samples that tested negative for opiates 36-65% over a one-year period. 4 The Food and Drug Administration s approval of buprenorphine (subutex and suboxone) for treating addiction to heroin or other opioids, including prescription painkillers, on October 8, 2002, marks a milestone in NIDA's medication development program. Drug Treatment During and After Imprisonment Not Only Increases the Number of People Who Are Drug-Free., but Also Increases the Number of People Who are Arrest- Free Delaware Corrections- Based Therapeutic Community Treatment Continuum % Arrest- Free Since Release at 42- Month Followup Source: Inciardi et al.,

5 Page 5 of 8 A Continuing Care Strategy is Needed for Addiction as in Other Diseases Ongoing Treatment Works for Addiction and Hypertension, as Illustrated in this Hypothetical Example Source: McLellan et al., Many chronic conditions such as diabetes, depression, hypertension, and asthma require continual care in order for treatment benefits to be sustained. Addiction is similar to other chronic diseases in this regard. It requires monitoring of patient status on a regular basis, early intervention regarding possible problems, and proper referrals in order to maintain positive treatment effects. Drug abuse is chronic in most cases. It can t be treated like a broken leg or appendicitis. Drug Abuse and HIV/AIDS are Intertwined Epidemics

6 Page 6 of 8 4 out of 10 U.S. AIDS deaths are related to drug abuse. Estimated AIDS Incidence in the United States among Adults and Adolescents, by Sex and Exposure Category Source: Centers for Disease Control and Prevention, The portion of AIDS cases related to drug abuse has steadily increased over the course of the past two decades and intravenous drug use continues to be a major contributing cause to the increase in new cases.

7 Page 7 of 8 Drug Addiction Treatment IS HIV Prevention HIV Seroconversion at 18- Month Follow- Up is Decreased by Drug Addiction Treatment Source: Metzger et al., Studies have shown that drug treatment can dramatically reduce the rate at which people acquire HIV. Partial Recovery of Brain Function with Prolonged Abstinence from Drug Use

8 Page 8 of 8 9 Source: Volkow et al., NIDA Home Site Map Search FAQs Accessibility Help Privacy FOIA (NIH) Employment Print Version _ The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, February 2, 2005.

Prevention Can Work. SELECT A TOPIC...

Prevention Can Work.   SELECT A TOPIC... Page 1 of 5 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Prevention Can Work Preventing Drug Abuse is Our Most Effective Approach to

More information

Magnitude. SELECT A TOPIC...

Magnitude.  SELECT A TOPIC... Page 1 of 6 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Magnitude Drug Abuse is Costly Drug abuse is a major public health problem

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

IBR HOME PAGE WHAT S NEW ABOUT IBR RESOURCE COLLECTIONS STAFF PROJECTS NEWSLETTERS PUBLICATIONS PRESENTATIONS MANUALS FORMS OTHER LINKS

IBR HOME PAGE WHAT S NEW ABOUT IBR RESOURCE COLLECTIONS STAFF PROJECTS NEWSLETTERS PUBLICATIONS PRESENTATIONS MANUALS FORMS OTHER LINKS Evidence-Based Model Staff Resources Climate Interventio ntionsns T Family & Friends Skills Personal Health Support Alcohol and Offenders: The Alcohol and Addiction and The Alcohol and Addiction and Prevention

More information

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained

More information

Overview of. Treatment Outcome Studies from DATOS

Overview of. Treatment Outcome Studies from DATOS Drug Abuse Treatment Outcome (Funded by NIDA) Overview of Treatment Outcome from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric

More information

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

In 2008, an estimated 282,000 persons

In 2008, an estimated 282,000 persons National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Similarities and Differences in Opioid Treatment Programs that Provide Methadone Maintenance or Buprenorphine Maintenance

More information

The Importance of Psychological Treatment and Behavioral Support

The Importance of Psychological Treatment and Behavioral Support The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Aetna s Initiative on the Opioid Epidemic

Aetna s Initiative on the Opioid Epidemic Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than

More information

MARRCH Minnesota Society of Addiction Medicine Presents. Addiction as a Brain Disease

MARRCH Minnesota Society of Addiction Medicine Presents. Addiction as a Brain Disease MARRCH 2008 Minnesota Society of Addiction Medicine Presents Addiction as a Brain Disease Gavin Bart, MD Charles Reznikoff, MD Steven Fu, MD, MSCE David Frenz, MD, MS October 22, 2008 Schedule 10:00-12:00

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

Mass General s Substance Use Disorder Initiative

Mass General s Substance Use Disorder Initiative Mass General s Substance Use Disorder Initiative Martha Kane, PhD Sarah Wakeman, MD, FASAM Clinical and Medical Directors, Mass General Hospital Substance Use Disorder Initiative None Disclosures Objectives

More information

Substance Abuse Suboxone Treatment

Substance Abuse Suboxone Treatment Substance Abuse Suboxone Treatment Program Waterbury Hospital Infectious Disease Clinic Richard Smith, LCSW Leonard Savage, Consumer Steven I. Aronin, MD FACP, Program Director Ryan White All Grantee Meeting

More information

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year

More information

Effective Substance Abuse Treatment in The Criminal Justice System

Effective Substance Abuse Treatment in The Criminal Justice System 1 Effective Substance Abuse Treatment in The Criminal Justice System Redonna K. Chandler, Ph.D. Acting Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse,

More information

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted

More information

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR

More information

National Conference of State Legislators

National Conference of State Legislators National Conference of State Legislators Mark W. Parrino, M.P.A. Monday, July 20, 2009 Philadelphia, PA Medication Assisted Treatment for Opiate Addiction In the Criminal Justice System Updated August

More information

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders State of Connecticut Department of Mental Health and Addiction Services State Innovations in Prevention and Treatment of Opioid Use Disorders National Academy for State Health Policy October 23, 2017 ~

More information

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC Robert L. DuPont, M.D. President, Institute for Behavior and Health, Inc. 2 nd Annual Symposium on Addiction

More information

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic What should we do with this case? 17 M Onset prescription opioids 15, progressing to daily use with withdrawal within 8 months Onset

More information

NIDA Principles of Treatment. NIDA Principles of Treatment. Peter Banys, M.D., M.Sc. No single treatment is appropriate for all individuals.

NIDA Principles of Treatment. NIDA Principles of Treatment. Peter Banys, M.D., M.Sc. No single treatment is appropriate for all individuals. NIDA Principles of Treatment Peter Banys, M.D., M.Sc. CSAM Addiction Medicine Review Course San Francisco October 5 th, 2006 NIDA Principles of Treatment 1. Treatment Matching 2. Availability 3. Domains

More information

New London CARES Coordinated Access, Resources, Engagement and Support

New London CARES Coordinated Access, Resources, Engagement and Support New London CARES Coordinated Access, Resources, Engagement and Support What are Opioids? Class of drugs that include Heroin Prescription pain relievers oxycodone (OxyContin), hydrocodone (Vicodin), codeine,

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

Treatment Team Approaches in Substance Abuse Treatment

Treatment Team Approaches in Substance Abuse Treatment Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

IntNSA Webinar Series

IntNSA Webinar Series BUPRENORPHINE CLINIC: A MULTIDISCIPLINARY MODEL FOR OPIOID MAINTENANCE THERAPY Stephen Strobbe, PhD, RN, NP, PMHCNS-BC, CARN-AP Monday, June 4, 2012 IntNSA Webinar Series Funding for this webinar was made

More information

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February

More information

ROSC & MAT II: Opioid Treatment Services

ROSC & MAT II: Opioid Treatment Services ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify

More information

THE STATE OF MEDICINE IN ADDICTION RECOVERY

THE STATE OF MEDICINE IN ADDICTION RECOVERY OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine

More information

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program

More information

What Predicts the Successful Completion of Addiction Treatment?

What Predicts the Successful Completion of Addiction Treatment? What Predicts the Successful Completion of Addiction Treatment? Bushauna A Freeman -Dr. Metzger SUMR PROGRAM 2016 Philadelphia, PA August 17, 2016 Overview Background Addiction and Medication Assisted

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

The role of behavioral interventions in buprenorphine treatment of opioid use disorders

The role of behavioral interventions in buprenorphine treatment of opioid use disorders The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies

More information

The Magnitude of the Problem

The Magnitude of the Problem Testimony on Senate Bill 860 Criminal Justice and Addiction Treatment Act Drs. Sheryl Ryan, Chief Adolescent Medicine and Leslie Walker-Harding, Chair of the Department of Pediatrics Penn State Health

More information

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS

More information

How serious is the opiate problem in Fairfield County?

How serious is the opiate problem in Fairfield County? How serious is the opiate problem in Fairfield County? The Use of Opiates in Fairfield County has increased from levels in the 1990's that were barely detectable to epidemic proportions in 2010. How serious

More information

Supporting Sustained Recovery for Opioid Use Disorder

Supporting Sustained Recovery for Opioid Use Disorder Supporting Sustained Recovery for Opioid Use Disorder RCPA Conference Hershey, PA October 3, 2018 Agenda Scope of the opioid epidemic Medication-assisted treatment (MAT) What does MAT involve? What are

More information

STARTING SUBOXONE IN PRIMARY CARE

STARTING SUBOXONE IN PRIMARY CARE Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences STARTING SUBOXONE IN PRIMARY CARE MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Review evidence of how to

More information

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT/FIT 2016 April 2016 Daniel P. Alford, MD, MPH Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research and Education

More information

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 AN ENHANCED MEDICAL HOME MODEL FOR THE SMI POPULATION Comprehensive Care Patient Centered Care Coordinated Care Accessible Services Quality

More information

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in

More information

2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders

2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,

More information

Opioid Use Disorders as a Brain Disease Why MAT is so important. Ron Jackson, M.S.W., L.I.C.S.W.

Opioid Use Disorders as a Brain Disease Why MAT is so important. Ron Jackson, M.S.W., L.I.C.S.W. Opioid Use Disorders as a Brain Disease Why MAT is so important Ron Jackson, M.S.W., L.I.C.S.W. Affiliate Professor School of Social Work University of Washington Organization Name: CareOregon Course Title:

More information

State Opioid Response (SOR) Grant

State Opioid Response (SOR) Grant State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics

More information

Brief History of Methadone Maintenance Treatment

Brief History of Methadone Maintenance Treatment METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what

More information

Project Connections Buprenorphine Program

Project Connections Buprenorphine Program Project Connections Buprenorphine Program Program & Client Summary 2010-2017 Behavioral Health Leadership Institute November 2017 November 2017 1 Table of Contents I. Overview of the Project Connections

More information

Overview of Adolescent Substance Abuse & Treatment

Overview of Adolescent Substance Abuse & Treatment Overview of Adolescent Substance Abuse & Treatment Joan E. Zweben, Ph.D. Executive Director, EBCRP Clinical Professor of Psychiatry, UCSF PREP Program Training June 23, 2011 Adolescent Substance Use Critical

More information

Medication for Addiction Treatment (MAT)

Medication for Addiction Treatment (MAT) SBIRT Training Screening, Brief Intervention & Referral to Treatment Medication for Addiction Treatment (MAT) The Faith & Spirituality Integrated SBIRT Network Navigating the Training Welcome! These health

More information

Addressing Opiate Abuse

Addressing Opiate Abuse Addressing Opiate Abuse William B. Lawson, MD, PhD, DLFAPA Associate Dean of Health Disparities University of Texas at Austin Dell Medical School william.lawson@austin.utexas.edu Opioids Medications that

More information

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Restoration of Parenting Ability Through Treatment for Substance Use Disorders Restoration of Parenting Ability Through Treatment for Substance Use Disorders DEBRA M. BARNETT, MD Board Certified in General Psychiatry, Addiction Psychiatry, Geriatric Psychiatry, and Forensic Psychiatry

More information

COMPILATION OF TEACHER EDITIONS. Heads Up: Real News. About Drugs and Your Body

COMPILATION OF TEACHER EDITIONS. Heads Up: Real News. About Drugs and Your Body COMPILATION OF 2006 7 TEACHER EDITIONS Heads Up: Real News About Drugs and Your Body Lessons and Reproducibles Inside This Compilation: The Science of Addiction Page 1 Tobacco Addiction and Secondhand

More information

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Alexander Y. Walley, MD, MSc Associate Professor of Medicine Director, Addiction Medicine Fellowship Boston University

More information

Recommendation #1: Expand Drug Courts

Recommendation #1: Expand Drug Courts The criminal justice system affords a unique opportunity to intervene with dysfunctional drug abusers in the state. Drug courts provide a way to identify and divert those juvenile and adult arrestees who

More information

Testimony on behalf of the FRIENDS OF NIDA COALITION. Regarding the Fiscal Year 2007 Appropriation for the. National Institute on Drug Abuse

Testimony on behalf of the FRIENDS OF NIDA COALITION. Regarding the Fiscal Year 2007 Appropriation for the. National Institute on Drug Abuse Testimony on behalf of the FRIENDS OF NIDA COALITION Regarding the Fiscal Year 2007 Appropriation for the National Institute on Drug Abuse before the United States House of Representatives Committee on

More information

Science = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse

Science = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse Advancing Addiction Science Science = Solutions Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse John Smith James Smith Ann

More information

Presbyterian Centennial Care. Substance Use Disorder Services and Supports

Presbyterian Centennial Care. Substance Use Disorder Services and Supports Presbyterian Centennial Care Substance Use Disorder Services and Supports National Comparison Data National Survey on Drug Use and Health: Comparison of 2002-2003 and 2011-2012 Model-Based Prevalence Estimates

More information

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016) What do we mean by the opioid crisis? 83 Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016) 675,315,375 Opioid pills dispensed in North Carolina in 2016 SOURCE:

More information

What is harm reduction?

What is harm reduction? What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive

More information

Addiction as a Neuropsychiatric Medical Condition

Addiction as a Neuropsychiatric Medical Condition Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary

More information

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased

More information

National Institute on Drug Abuse Principles of Drug Abuse Treatment for Criminal Justice Populations A Research-Based Guide

National Institute on Drug Abuse Principles of Drug Abuse Treatment for Criminal Justice Populations A Research-Based Guide National Institute on Drug Abuse Principles of Drug Abuse Treatment for Criminal Justice Populations A Research-Based Guide 1 NIH Publication No. 11-5316 Printed September 2006, Revised September 2007,

More information

The Opioid Scourge DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER

The Opioid Scourge DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER The Opioid Scourge NOUN: A PERSON OR THING THAT CAUSES GREAT TROUBLE OR SUFFERING SYNONYMS: AFFLICTION, BANE, CURSE, MENACE, BURDEN, EVIL DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER 1,000,000,000,000 72,000

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice May 2013 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Case 32 yo female brought in after heroin overdose

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

Addicted, Alone, Forgotten, and Ashamed

Addicted, Alone, Forgotten, and Ashamed Addicted, Alone, Forgotten, and Ashamed Colleen T. LaBelle, MSN, RN-BC, CARN Nurse Manager, Office-Based Addiction Treatment Director, STATE OBAT, Mass Department Public Health Overdose Deaths per 100,000

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South

More information

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns

More information

MAT - ICAAD 2018 Ron Jackson, MSW, LICSW

MAT - ICAAD 2018 Ron Jackson, MSW, LICSW The ATTC Network Ten Regional Centers northwest@attcnetwork.org www.attcnetwork.org/northwest phone. 206-685-4419 1107 NE 45 th St, Ste 120, Seattle, WA 98105 http://attcnetwork.org/northwest U.S. Opioid

More information

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic

More information

AN#EXCERPT#(PAGES'1'!29)!FROM( THE$NATIONAL'INSTITUTE'ON!DRUG%ABUSE( PRINCIPLES)OF!DRUG%ADDICTION%AND%TREATMENT:( A"RESEARCH"BASED"GUIDE(

AN#EXCERPT#(PAGES'1'!29)!FROM( THE$NATIONAL'INSTITUTE'ON!DRUG%ABUSE( PRINCIPLES)OF!DRUG%ADDICTION%AND%TREATMENT:( ARESEARCHBASEDGUIDE( READING(MATERIAL(FOR(THE(FREE(STATE(SOCIAL(WORK,(LLC(COURSE(( PRINCIPLES)OF)DRUG)ADDICTION)TREATMENT)AND)FREQUENTLY)ASKED)QUESTIONS) ( ( ( ( ABOUT(THIS(READING(MATERIAL:((( AN#EXCERPT#(PAGES'1'!29)!FROM(

More information

2/21/2018. What are Opioids?

2/21/2018. What are Opioids? Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation

More information

PHMC Integrated Health Services Overview

PHMC Integrated Health Services Overview PHMC Integrated Health Services Overview Dinetta Armstrong Managing Director Health Services Who is PHMC? Nonprofit public health institute Serving the city/region since 1972 Provides direct services,

More information

Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)

Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition) National Institute on Drug Abuse (NIDA) Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition) Last Updated January 2018 https://www.drugabuse.gov 1 Table of Contents Principles

More information

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE HEALTH WEALTH CAREER ADDING EVEN MORE SUBSTANCE TO MANAGED CARE OPTIMIZING MEDICAID TO RESPOND TO SUBSTANCE USE DISORDERS NATIONAL ACADEMY FOR STATE HEALTH POLICY 30TH ANNUAL STATE HEALTH POLICY CONFERENCE

More information

New Jersey Department of Human Services Division of Mental Health and Addiction Services Substance Abuse Treatment State Performance Report

New Jersey Department of Human Services Division of Mental Health and Addiction Services Substance Abuse Treatment State Performance Report New Jersey Department of Human Services Substance Abuse Treatment January 1, 2016 - December 31, 2016 Prepared by: Office of Planning, Research, Evaluation and Prevention June 2017 : 1/1/2016-12/31/2016

More information

New Jersey Department of Health Division of Mental Health and Addiction Services Substance Abuse Treatment State Performance Report

New Jersey Department of Health Division of Mental Health and Addiction Services Substance Abuse Treatment State Performance Report New Jersey Department of Health Substance Abuse Treatment July 1, 2016 - June 30, 2017 Prepared by: Office of Planning, Research, Evaluation and Prevention October 2017 : 07/01/2016-06/30/2017 Primary

More information

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Opioid use in pregnancy and Neonatal Abstinence Syndrome Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,

More information